Extracellular histones as damage-associated molecular patterns in neuroinflammatory responses
Author:
Richards Christy M.1, McRae Seamus A.1, Ranger Athena L.1, Klegeris Andis1ORCID
Affiliation:
1. Department of Biology , University of British Columbia Okanagan Campus , Kelowna V1V 1V7 , BC , Canada
Abstract
Abstract
The four core histones H2A, H2B, H3, H4, and the linker histone H1 primarily bind DNA and regulate gene expression within the nucleus. Evidence collected mainly from the peripheral tissues illustrates that histones can be released into the extracellular space by activated or damaged cells. In this article, we first summarize the innate immune-modulatory properties of extracellular histones and histone-containing complexes, such as nucleosomes, and neutrophil extracellular traps (NETs), described in peripheral tissues. There, histones act as damage-associated molecular patterns (DAMPs), which are a class of endogenous molecules that trigger immune responses by interacting directly with the cellular membranes and activating pattern recognition receptors (PRRs), such as toll-like receptors (TLR) 2, 4, 9 and the receptor for advanced glycation end-products (RAGE). We then focus on the available evidence implicating extracellular histones as DAMPs of the central nervous system (CNS). It is becoming evident that histones are present in the brain parenchyma after crossing the blood-brain barrier (BBB) or being released by several types of brain cells, including neurons, microglia, and astrocytes. However, studies on the DAMP-like effects of histones on CNS cells are limited. For example, TLR4 is the only known molecular target of CNS extracellular histones and their interactions with other PRRs expressed by brain cells have not been observed. Nevertheless, extracellular histones are implicated in the pathogenesis of a variety of neurological disorders characterized by sterile neuroinflammation; therefore, detailed studies on the role these proteins and their complexes play in these pathologies could identify novel therapeutic targets.
Publisher
Walter de Gruyter GmbH
Subject
General Neuroscience
Reference202 articles.
1. Abbott, N.J. (2013). Blood-brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis. 36: 437–449, https://doi.org/10.1007/s10545-013-9608-0. 2. Abrams, S.T., Zhang, N., Dart, C., Wang, S.S., Thachil, J., Guan, Y., Wang, G., and Toh, C.H. (2013a). Human CRP defends against the toxicity of circulating histones. J. Immunol. 191: 2495–2502, https://doi.org/10.4049/jimmunol.1203181. 3. Abrams, S.T., Zhang, N., Manson, J., Liu, T., Dart, C., Baluwa, F., Wang, S.S., Brohi, K., Kipar, A., Yu, W., et al.. (2013b). Circulating histones are mediators of trauma-associated lung injury. Am. J. Respir. Crit. Care Med. 187: 160–169, https://doi.org/10.1164/rccm.201206-1037oc. 4. Akirav, E.M., Preston-Hurlburt, P., Garyu, J., Henegariu, O., Clynes, R., Schmidt, A.M., and Herold, K.C. (2012). RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS One 7: 34698, https://doi.org/10.1371/journal.pone.0034698. 5. Alhamdi, Y., Abrams, S.T., Cheng, Z., Jing, S., Su, D., Liu, Z., Lane, S., Welters, I., Wang, G., and Toh, C.H. (2015). Circulating histones are major mediators of cardiac injury in patients with sepsis. Crit. Care Med. 43: 2094–2103, https://doi.org/10.1097/ccm.0000000000001162.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|